Follow the 옵티팜 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 옵티팜 has recorded 37 reports. The latest transaction was reported on 29 June 2026 (Purchase). Among the most active insiders: 김현일. The full history is accessible without an account.
37
Insider Decl.
n/a
Thresholds
€5,670
35 ops.
Buy Volume
n/a
1 ops.
Sell Volume
22Σ signal
Buys €5,670n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
OptiPharm is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on the development and distribution of innovative pharmaceutical products.